ONCO Stock Analysis: Buy, Sell, or Hold?

ONCO - Onconetix, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.89
-0.01 (-1.34%) â–ŧ
5d: +7.85%
30d: -9.48%
90d: +120.69%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026 4d

Get Alerted When ONCO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: ONCO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ONCO is currently trading at $0.89, which is considered fair relative to its 30-day fair value range of $0.79 to $1.00.

Technical Outlook: Technically, ONCO is showing sideways momentum. Immediate support is located at $0.67, while resistance sits at $1.01.

Market Sentiment: ONCO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+909.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.79 - $1.00
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 909.4% below Wall St target ($9.00)
  • WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $0.79 - $1.00
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.67
Resistance Level $1.01
Current Trend Sideways
Technical data as of Aug 7, 2026

Fundamental Context

Wall Street Target $9.00 (+909.4%)
Revenue Growth (YoY) -78.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 08, 2026 6:38 AM ET
Data refreshes hourly during market hours. Next update: 7:38 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
NEUTRAL
Recent Transactions
Financial Lp Hrt SELL 49710 shares 2026-04-21
Financial Lp Hrt SELL 94462 shares 2026-04-20
Financial Lp Hrt BUY 34636 shares 2026-04-17

Unlock Insider Activity

See real-time buying/selling by company executives for ONCO.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$87 54 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$196 48 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$108 60 HOLD
VRTX
Vertex Pharmaceuticals Iâ€Ļ
BUY
34 analysts
$557 45 HOLD
CRNX
Crinetics Pharmaceuticalâ€Ļ
STRONG BUY
17 analysts
$86 46 HOLD

More Analysis for ONCO

ONCO Technical Chart ONCO Price Prediction ONCO Earnings Date ONCO Investment Advisor ONCO Fair Price Analyzer ONCO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals